What Researchers Did
Researchers presented a case report about a 55-year-old woman with recurrent cervical cancer who received hyperbaric oxygen therapy for severe radiation fibrosis and unhealed wounds.
What They Found
The patient died one month after completing hyperbaric oxygen therapy, and an autopsy showed widespread cancer (carcinomatosis) throughout her abdominal cavity and lower abdominal wall. This outcome suggested a rapid progression of her squamous cell carcinoma of the cervix following the treatment.
What This Means for Canadian Patients
This case report suggests a potential risk of rapid cancer progression in patients with active or recurrent cancer who undergo hyperbaric oxygen therapy for complications like radiation injury. Canadian patients with similar conditions should discuss these potential risks thoroughly with their healthcare providers before considering HBOT.
Canadian Relevance
This study covers delayed radiation injury and unhealed wounds, which are related to Health Canada-recognized indications for hyperbaric oxygen therapy. However, the study itself is not Canadian and does not involve Canadian authors.
Study Limitations
As a single case report, these findings cannot be generalized to all patients and do not definitively prove that hyperbaric oxygen therapy caused the rapid cancer progression.